nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter Cohort
|
Lucchetti, Jessica |
|
|
24 |
2 |
p. 207-217.e5 |
artikel |
2 |
AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG)
|
Burge, Matthew E. |
|
|
24 |
2 |
p. 120-128 |
artikel |
3 |
A Phase Two, Single-Arm, Open-Label Study With Dostarlimab Monotherapy in Participants With Untreated Stage II/III dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1)
|
Cercek, Andrea |
|
|
24 |
2 |
p. 325-330 |
artikel |
4 |
Association Between Colorectal Cancer Primary Features and Liver Metastases Histological Growth Patterns: Inflammation on the Primary Tumor is Associated with Desmoplastic Growth Pattern
|
Abrantes, Ana Margarida |
|
|
24 |
2 |
p. 239-247 |
artikel |
5 |
Circulating Tumor DNA in Addition to Fecal Immunochemical Test in a Dual-Test Colorectal Cancer Screening Approach
|
Kahn, Caroline L. |
|
|
24 |
2 |
p. 310-319.e1 |
artikel |
6 |
Does Extramural Vascular Invasion Predict Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer?
|
Bhutiani, Neal |
|
|
24 |
2 |
p. 272-279.e2 |
artikel |
7 |
Editorial Board
|
|
|
|
24 |
2 |
p. A1 |
artikel |
8 |
Escalated Segmental and Modified Radiation Lobectomy Dosing for Yttrium-90 Radioembolization of Liver-Dominant Metastatic Colorectal Cancer: 10-year Outcomes
|
Gordon, Andrew C |
|
|
24 |
2 |
p. 290-299 |
artikel |
9 |
Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS-/BRAF-Mutated Metastatic Colorectal Cancer
|
Hamfjord, Julian |
|
|
24 |
2 |
p. 153-158 |
artikel |
10 |
Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial
|
Taieb, Julien |
|
|
24 |
2 |
p. 180-187.e4 |
artikel |
11 |
Impact of Upfront DPYD Genotyping on Fluoropyrimidine Adjuvant Therapy in Colorectal Cancer: A Real-World Data
|
Saarenheimo, Jatta |
|
|
24 |
2 |
p. 264-271 |
artikel |
12 |
Incidence and Outcomes of Patients With Mismatch Repair Deficient Rectal Cancer Operated in 2016: A Nationwide Cohort From The Netherlands
|
van Geffen, Eline G.M. |
|
|
24 |
2 |
p. 188-197.e1 |
artikel |
13 |
Lack of Hierarchical Survival Prognosis in AJCC Staging for Colon and Rectal Cancer—Implications for Future Summary Stage Classification
|
Bhutiani, Neal |
|
|
24 |
2 |
p. 159-165.e2 |
artikel |
14 |
Multidisciplinary Team Meeting Significantly Enhances Disease-Free Survival in Stage II-III Rectal Cancer
|
Jiang, Wenheng |
|
|
24 |
2 |
p. 198-206.e5 |
artikel |
15 |
Number of Lymph Nodes Examined as a Prognosis Factor in Patients With Stage II or III Colon Cancer
|
Kim, Hyunwook |
|
|
24 |
2 |
p. 280-289.e4 |
artikel |
16 |
Oncological Outcomes From Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases
|
Tinsley, Nadina |
|
|
24 |
2 |
p. 166-179 |
artikel |
17 |
Organ Preservation After Immune Checkpoint Inhibition for Locally Advanced Rectal Cancer
|
Claeys, Charlotte |
|
|
24 |
2 |
p. 320-324 |
artikel |
18 |
Outcomes of Elderly Patients With Node-Positive Colon Cancer: A Multicenter Population-Based Cohort Study
|
Pinter, Carl |
|
|
24 |
2 |
p. 143-152 |
artikel |
19 |
Prognostic Value of External Iliac Lymph Node (N1b) Metastasis in Anal Carcinoma and Validation of a New Stage Grouping System
|
Xu, Hong'en |
|
|
24 |
2 |
p. 248-255.e2 |
artikel |
20 |
Prognostic Values of Pre- and Post-Therapeutic FDG-PET in Anal Canal Cancer: Analysis of a Prospective Study
|
Zwarthoed, C. |
|
|
24 |
2 |
p. 256-263.e8 |
artikel |
21 |
Rectosigmoid Junction Cancer; The Role of Preoperative and Postoperative Radiation With Novel Nomogram in Predicting Survival in the United States
|
Khan, Marjan |
|
|
24 |
2 |
p. 135-142 |
artikel |
22 |
SATB2 Expression Affects Chemotherapy Metabolism and Immune Checkpoint Gene Expression in Colorectal Cancer
|
Maguire, Barry |
|
|
24 |
2 |
p. 129-134.e7 |
artikel |
23 |
Significant Alterations of Colorectal Cancer Care in the COVID-19 Pandemic With High Adherence to Quality Criteria in German Cancer Centers (CC) ‒ Data From the AIO CancerCOVID Consortium (AIO-YMO/KRK 520/ass)
|
Lugnier, Céline |
|
|
24 |
2 |
p. 218-230 |
artikel |
24 |
Table of contents
|
|
|
|
24 |
2 |
p. A3-A8 |
artikel |
25 |
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC)
|
Schietroma, Francesco |
|
|
24 |
2 |
p. 231-238 |
artikel |
26 |
Treatment Adherence to Adjuvant Chemotherapy According to the New Standard 3-month CAPOX Regimen in High-risk Stage II and Stage III Colon Cancer: A Population-based Evaluation in The Netherlands
|
van den Berg, Kim |
|
|
24 |
2 |
p. 300-309 |
artikel |
27 |
What the Clinician Needs to Know About Laboratory Analyses of Circulating Tumor DNA
|
Jacobsen, Cecilie Mondrup |
|
|
24 |
2 |
p. 109-119 |
artikel |